Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04501887
Status:
UNKNOWN
Last Update Posted:
2020-08-06
First Post:
2020-08-04
Brief Title:
The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Shanghai Zhongshan Hospital
Study Overview
Official Title:
The Efficacy of Precision Treatment for Gastric Cancer Guided by Multidimensional Molecular Biology Profiling a Multi-center Clinical Study
Status:
UNKNOWN
Status Verified Date:
2020-08
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Gastric cancer GC is one of the most common and lethal cancers worldwide especially in China and the median overall survival for patients with advanced metastatic GC remains only about 1 year Several molecular profiling studies have demonstrated that a proportion of gastric cancer harbour actionable molecular alterations which shows a predictive benefit from a specific therapy in any cancer type In the current study the efficacy of precision treatment for gastric cancer guided by multidimensional molecular biology profiling will be observed The analysis focused on the overall survival outcomes for patients whose tumours harboured actionable molecular alterations and who received appropriately matched therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None